MedTrace Logo

Psoriasis and Its Impact on Quality of Life Among Psoriatic Patients

NCT07709169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2026-07-16

No results posted yet for this study

Summary

This work aimed to study some epidemiological features and the clinical profile of patients having psoriasis visiting the Dermatology and Venereology departments of Tanta University Hospitals and to assess the impact of disease on their quality of life.

Conditions

Interventions

OTHER

Quality of Life assessment

Patients completed the Dermatology Life Quality Index (DLQI), which includes 10 questions and is designed for use in adults. Each question is scored on a 4-point scale from 0 ("Not at all") to 3 ("Very much") to assess the past seven days, providing a total score ranging from 0 to 30: 0 - 1: No effect at all on patient's life. 2 - 5: Small effect on patient's life. 6 - 10: Moderate effect on patient's life. 11 - 20: Very large effect on patient's life. 21 - 30: Extremely large effect on patient's life.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07709169 on ClinicalTrials.gov